Shiota G - Search Results

1

Synergistic effects of (-)-epigallocatechin gallate with sulindac against colon carcinogenesis of rats treated with azoxymethane.

Ohishi T, Kishimoto Y, Miura N, Shiota G, Kohri T, Hara Y, Hasegawa J, Isemura M. Ohishi T, et al. Among authors: shiota g. Cancer Lett. 2002 Mar 8;177(1):49-56. doi: 10.1016/s0304-3835(01)00767-4. Cancer Lett. 2002. PMID: 11809530

2

Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane.

Kishimoto Y, Morisawa T, Hosoda A, Shiota G, Kawasaki H, Hasegawa J. Kishimoto Y, et al. Among authors: shiota g. J Exp Clin Cancer Res. 2002 Jun;21(2):203-11. J Exp Clin Cancer Res. 2002. PMID: 12148579

3

Effects of long-term administration of sulindac on APC mRNA and apoptosis in colons of rats treated with azoxymethane.

Kishimoto Y, Yashima K, Morisawa T, Ohishi T, Marumoto A, Sano A, Idobe-Fujii Y, Miura N, Shiota G, Murawaki Y, Hasegawa J. Kishimoto Y, et al. Among authors: shiota g. J Cancer Res Clin Oncol. 2002 Nov;128(11):589-95. doi: 10.1007/s00432-002-0384-8. Epub 2002 Oct 4. J Cancer Res Clin Oncol. 2002. PMID: 12458338

4

Effects of cyclooxygenase-2 inhibitor NS-398 on APC and c-myc expression in rat colon carcinogenesis induced by azoxymethane.

Kishimoto Y, Yashima K, Morisawa T, Shiota G, Kawasaki H, Hasegawa J. Kishimoto Y, et al. Among authors: shiota g. J Gastroenterol. 2002;37(3):186-93. doi: 10.1007/s005350200019. J Gastroenterol. 2002. PMID: 11931531

5

Sulindac and a cyclooxygenase-2 inhibitor, etodolac, increase APC mRNA in the colon of rats treated with azoxymethane.

Kishimoto Y, Takata N, Jinnai T, Morisawa T, Shiota G, Kawasaki H, Hasegawa J. Kishimoto Y, et al. Among authors: shiota g. Gut. 2000 Dec;47(6):812-9. doi: 10.1136/gut.47.6.812. Gut. 2000. PMID: 11076880 Free PMC article.

6

Clinical usefulness of serum telomerase reverse transcriptase (hTERT) mRNA and epidermal growth factor receptor (EGFR) mRNA as a novel tumor marker for lung cancer.

Miura N, Nakamura H, Sato R, Tsukamoto T, Harada T, Takahashi S, Adachi Y, Shomori K, Sano A, Kishimoto Y, Ito H, Hasegawa J, Shiota G. Miura N, et al. Among authors: shiota g. Cancer Sci. 2006 Dec;97(12):1366-73. doi: 10.1111/j.1349-7006.2006.00342.x. Cancer Sci. 2006. PMID: 17052260 Free article.

7

Serum human telomerase reverse transcriptase messenger RNA as a novel tumor marker for hepatocellular carcinoma.

Miura N, Maeda Y, Kanbe T, Yazama H, Takeda Y, Sato R, Tsukamoto T, Sato E, Marumoto A, Harada T, Sano A, Kishimoto Y, Hirooka Y, Murawaki Y, Hasegawa J, Shiota G. Miura N, et al. Among authors: shiota g. Clin Cancer Res. 2005 May 1;11(9):3205-9. doi: 10.1158/1078-0432.CCR-04-1487. Clin Cancer Res. 2005. PMID: 15867214

8

Serum messenger RNA as a biomarker and its clinical usefulness in malignancies.

Miura N, Hasegawa J, Shiota G. Miura N, et al. Among authors: shiota g. Clin Med Oncol. 2008;2:511-27. doi: 10.4137/cmo.s379. Epub 2008 Sep 22. Clin Med Oncol. 2008. PMID: 21892326 Free PMC article.

9

Biomarkers for hepatocellular carcinoma.

Shiota G, Miura N. Shiota G, et al. Clin J Gastroenterol. 2012 Jun;5(3):177-82. doi: 10.1007/s12328-012-0301-x. Epub 2012 Apr 26. Clin J Gastroenterol. 2012. PMID: 26182317

10

Erratum to: Biomarkers for hepatocellular carcinoma.

Shiota G, Miura N. Shiota G, et al. Clin J Gastroenterol. 2012 Jun;5(3):245. doi: 10.1007/s12328-012-0310-9. Clin J Gastroenterol. 2012. PMID: 26182329 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

203 results

Search Page